Our trusted team of thought leaders provides the latest insights and perspectives on important health industry and management consulting trends and topics.
A large pharmaceutical company’s Data Science & AI team was looking for support to develop and scale their internal AI platform engine to power...
Are you ready for the Inflation Reduction Act? Assess your readiness and adapt strategies to thrive amid regulatory changes in the healthcare...
This structured approach guides Med Affairs leaders in executing micro-transformations to drive meaningful impact for your organization and patients.
To explore the critical intersection of Diversity, Equity, and Inclusion (DEI) with the Life Sciences supply chain.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies...
Read how a European-based regional HR organization within a Global Pharmaceutical company asked Vynamic to assess the current state of Diversity.
While awaiting approval to launch a new product, a large pharmaceutical company identified a need to revisit their market access strategy.
Vynamic brought strategic thinking, market expertise, and experience managing complex transformational programs to help a health insurer launch.
Patient centricity is no longer a buzzword. It’s redefining how the pharmaceutical industry operates. Watch how Vynamic strategically partnered.
Navigating changes in structure and responsibilities can present operational and cultural challenges for a team.
Enhancing the performance of omnichannel activities is now a priority for many life sciences companies.
Medical affairs plays a critical role in key activities for pharmaceutical companies. This includes evidence generation, evidence dissemination.
